Bath & Body Works stock
BBWINYSEBath & Body Works, Inc., Consumer CyclicalISIN US0708301041
69Score 69 out of 100, Neutral
Price and trend
66 / 100
Price history
−5.9% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 6.5% above it.
Since September 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 51).
The price is 15% below its 52-week high. Largest decline in 20 years: 91% (November 2015 to March 2020).
Chart figures for advanced users
- SMA 50$19.16
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$19.80
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)51
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$14.85
- The lowest closing price of the last twelve months.
- Resistance$24.67
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Bath & Body Works, Inc. belongs to the Specialty Retail industry (United States) and, with a market value of $4.25B, is number 43 of 86 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $7.29B (down 0.2% year on year) and earnings of $649M (down 18.7%).
- For fiscal 2026, analysts expect on average revenue of $7.11B (down 2.5%) and adjusted earnings per share of $2.70 (down 17.3%).
Show more
- MEQIRI Score 69 out of 100 (Neutral): rank 175 of 602 in Consumer Cyclical, median 61.
- The P/E is 5.5 (Specialty Retail median 23, own median of recent years 11).
- Our model puts fair value at $59.49, with the price 63% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Modestly valuedP/E 5.5, Specialty Retail median 23, own median 11.Valuation 82
- Below fair valuePrice 63% below the fair value of $59.49.Valuation 82
- Share buybacksShare count down 24% since 2020.Capital allocation 94
Weaknesses
- Volatile share priceVolatility 61% a year over the last 12 months.Stability 42
Its standout strengths are fundamentals and capital allocation, while stability and growth hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Fundamentals are strong, with stable profits and strong cash generation.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk low
How well MEQIRI warnsOne of the 30% with the lowest crash risk among smaller stocks.
From 2016 to 2025, 14 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- high price swings
What lowers it
- solid fundamentals
Valuation
Valuation signal
Significantly undervaluedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $39.66 and expensive above $118.99 (uncertainty very high, based on the price swings of the past year).
The two parts of the fair value come to $30.14 (cash-flow model) and $88.85 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.
Calculated with a cost of equity of 11.3%. At 12.3% the fair value would be $57.76, at 10.3% it would be $61.76.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (23).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 1 Aug 2026, revenue fell 2.2% on the twelve months before. Revenue has stayed largely stable since 2006.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 44%, operating 15%, net 9%.
Debt & balance sheet
latest quarterDebt is elevated. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 19 Nov 2026in 7 days
- Last reported
- 26 Aug 2026EPS reported $0.62 (expected $0.24)above expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $2.70−0.5%
- Revenue
- $7.11B0.0%
- Earnings per share
- $2.77+0.1%
- Revenue
- $7.22B0.0%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook raised
Share price after the results: +6.1%Fiscal 2026 adjusted earnings per share guidance raised to $2.60 to $2.80; net sales guidance narrowed by raising the low end to down 4% (high end stays at down 2.5%).
“We are also raising our adjusted earnings per diluted share guidance to $2.60 to $2.80, reflecting our second quarter outperformance and latest view of the business.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 26 Aug 2026 (fiscal Q2 2027), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases in the last 6 months. One insider sold, $14 in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
- Nash Sarah ESale
16 Oct 2026, Board
- Shares
- 0.69
- Price
- $20.57
- Value
- $14
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Bath & Body Works
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
602 rated companies in Consumer Cyclical
- This company
- 69
- Sector median
- 61
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Specialty Retail
The next larger and next smaller companies by market value
- Global-e OnlineGLBE $7.09B74
- Vipshop HoldingsVIPS $6.34B67
- ZOZO3092.T $6.28B75
- Vibra EnergiaVBBR3.SA $6.27B71
- Academy Sports and OutdoorsASO $4.27B72
- JumboBELA.AT $4.23B84
- FielmannFIE.DE $4.05B76
- Warby ParkerWRBY $3.76B50
ETFs that hold Bath & Body Works
Held by 15 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| WisdomTree US Equity Income UCITS ETF EUR Hedged AccWTDY | 0.29% | 0.35% | €204.34M |
| WisdomTree US High Dividend UCITS ETF AccWTD9 | 0.27% | 0.29% | €182.46M |
| State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETFZPRV | 0.20% | 0.30% | €944.34M |
Show 5 more
| State Street SPDR S&P 400 U.S. Mid Cap UCITS ETF (Acc)SPY4 | 0.13% | 0.30% | €5.27B |
| Franklin U.S. Equity UCITS ETFFLXU | 0.11% | 0.20% | €55.89M |
| iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETFSXRG | 0.09% | 0.43% | €2.48B |
| iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETFCBUG | 0.07% | 0.35% | €434.1M |
| Invesco Global Buyback Achievers UCITS ETFBBCK | 0.07% | 0.39% | €188.08M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Jan 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral since 7 Nov 2026, previously Strong
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.